DELTA & PINE LAND CO
10-Q, 1999-01-14
AGRICULTURAL PRODUCTION-CROPS
Previous: REXALL SUNDOWN INC, 10-Q, 1999-01-14
Next: DREYFUS PREMIER INSURED MUNICIPAL BOND FUND, 24F-2NT, 1999-01-14



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                    FORM 10-Q


(x)  Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange
     Act of 1934. For the quarterly period ended November 30, 1998.

or

( )  Transition Report Pursuant to Section 13 or 15(d) of the Securities 
     Exchange Act of 1934.  For the transition period from      to
                                                        ------   -------

                        Commission File Number: 000-21788

                  Exact name of registrant as specified in its charter:
                           DELTA AND PINE LAND COMPANY

                        State of Incorporation: Delaware
                I.R.S. Employer Identification Number: 62-1040440

           Address of Principal Executive Offices (including zip code):
                    One Cotton Row, Scott, Mississippi 38772

               Registrant's telephone number, including area code:
                                 (601) 742-4500


Indicate by check mark whether  Registrant (1) has filed all reports required to
be filed by Section 13 or 15(d) of the  Securities  Exchange  Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports)  and  (2)  has  been  subject  to such  filing
requirements for the past 90 days.

YES (x) NO ( )

Indicate the number of shares  outstanding  of each of the  issuer's  classes of
common stock, as of the latest practicable date:

Common Stock,  $0.10 Par Value - 38,407,793 shares  outstanding as of January 5,
1999.





<PAGE>

                  DELTA AND PINE LAND COMPANY AND SUBSIDIARIES

                                      INDEX
                                                                        Page No.
PART I.  FINANCIAL INFORMATION

   Item 1.   Consolidated Financial Statements 

             Consolidated Balance Sheets - November 30, 1997,
             August 31, 1998, and November 30, 1998                            3

             Consolidated Statements of Operations - Three Months
             Ended November 30, 1997 and November 30, 1998                     4

             Consolidated Statements of Cash Flows - Three Months
             Ended November 30, 1997 and November 30, 1998                     5

             Notes to Consolidated Financial Statements                        6

   Item 2.   Management's Discussion and Analysis of Financial
             Condition and Results of Operations                              12


PART II.  OTHER INFORMATION

   Item 4.   Submission of Matters to a Vote of Security Holders              22
   Item 6.   Exhibits and Reports on Form 8-K                                 22

                 Signatures                                                   23





<PAGE>
PART I. FINANCIAL INFORMATION
Item 1. Consolidated Financial Statements

                  DELTA AND PINE LAND COMPANY AND SUBSIDIARIES
                           CONSOLIDATED BALANCE SHEETS
                      (in thousands, except share amounts)
                                   (Unaudited)

<TABLE>
<CAPTION>
                                                                                            November 30,    August 31,  November 30,
                                                                                               1997           1998         1998
                                                                                            ----------      ----------  -----------
<S>                                                                                            <C>            <C>            <C>  
ASSETS
CURRENT ASSETS:
     Cash and cash equivalents                                                               $  4,140       $  8,062       $  5,625
     Receivables, net                                                                          11,000        104,779         13,246
     Inventories                                                                               74,596         50,497         92,511
     Prepaid expenses                                                                           1,878          1,194          3,661
     Income tax receivable                                                                      2,295          5,562          6,710
     Deferred income taxes                                                                      3,069          4,408          4,408
                                                                                                ------         ------        ------
         Total current assets                                                                  96,978        174,502        126,161
                                                                                              ---------      --------      --------
PROPERTY, PLANT and EQUIPMENT, net                                                             65,111         66,840         68,028

EXCESS OF COST OVER NET ASSETS OF
     BUSINESS ACQUIRED, net                                                                     4,659          4,583          4,549

INTANGIBLES, net                                                                                3,615          3,488          3,495

OTHER ASSETS                                                                                    2,515          2,378          2,232
                                                                                              ---------      --------      --------
                                                                                             $172,878       $251,791       $204,465
                                                                                              =========     =========      ========
LIABILITIES AND STOCKHOLDERS' EQUITY

CURRENT LIABILITIES:
     Notes payable                                                                           $ 11,995       $  1,263       $  1,263
     Accounts payable                                                                          32,673         22,831         33,239
     Accrued expenses                                                                          17,924         92,042         28,714
                                                                                              --------       --------      --------
         Total current liabilities                                                             62,592        116,136         63,216
                                                                                              ---------      --------      --------
LONG-TERM DEBT, less current maturities                                                        36,114         47,070         56,080

DEFERRED INCOME TAXES                                                                           4,038          5,020          5,020

MINORITY INTEREST IN SUBSIDIARIES                                                               1,149          2,914          5,611

STOCKHOLDERS' EQUITY:
     Preferred stock, par value $0.10 per share; 2,000,000 shares  authorized:
         Series A Junior Participating Preferred, par value $0.10 per share;
         429,319 shares authorized; no shares issued or outstanding                              --             --             --

          Series M Convertible Non-Voting Preferred,  par value $0.10 per share;
          1,066,666 shares authorized;  800,000 shares issued and outstanding                    80             80             80

     Common stock, par value $0.10 per share;
         100,000,000 shares authorized; 37,954,711; 38,469,616
         and  38,519,604 shares issued; 37,840,445; 38,355,350
         and 38,405,338 shares outstanding                                                      3,795          3,847          3,852
     
     Capital in excess of par value                                                            25,626         35,867         36,341

     Retained earnings                                                                         43,094         46,109         38,494

     Accumulated other comprehensive loss                                                       (1,437)        (3,079)       (2,056)

     Treasury stock at cost, 114,266; 114,266 and 114,266 shares                               (2,173)        (2,173)        (2,173)
                                                                                              --------       --------      --------
         Total stockholders' equity                                                            68,985         80,651         74,538
                                                                                              --------       --------      --------
                                                                                             $172,878       $251,791       $204,465
                                                                                             ========       =========      ========
</TABLE>
The accompanying notes are an integral part of these balance sheets.

<PAGE>

                  DELTA AND PINE LAND COMPANY AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF OPERATIONS
                           FOR THE THREE MONTHS ENDED
                    (in thousands, except per share amounts)
                                   (Unaudited)

<TABLE>
<CAPTION>

                                                                                November 30,               November 30,
                                                                                    1997                       1998
                                                                                -------------              ------------
<S>                                                                           <C>                      <C>             
NET SALES AND LICENSING FEES                                                  $        5,340           $          7,195
COST OF SALES                                                                          3,273                      4,947
                                                                                ------------                -----------
GROSS PROFIT                                                                           2,067                      2,248
                                                                                ------------                -----------
OPERATING EXPENSES:
     Research and development                                                          3,632                      4,235
     Selling                                                                           2,876                      3,829
     General and administrative                                                        2,602                      2,960
     Unusual charges related to acquisitions                                              47                        818
                                                                                ------------              -------------
                                                                                       9,157                     11,842
                                                                                ------------              -------------
OPERATING  LOSS                                                                       (7,090)                    (9,594)
INTEREST EXPENSE, net of capitalized interest of $57 and $32                            (343)                      (531)
OTHER                                                                                     66                       (237)
                                                                                -------------              -------------
LOSS  BEFORE INCOME TAXES                                                             (7,367)                   (10,362)
INCOME TAX BENEFIT                                                                     2,726                      3,923
                                                                                -------------               -------------
NET LOSS                                                                              (4,641)                    (6,439)
DIVIDENDS ON PREFERRED STOCK                                                             (24)                       (24)
                                                                                -------------              -------------
NET LOSS APPLICABLE TO COMMON SHARES                                            $     (4,665)         $          (6,463)
                                                                                ===============        ==================
BASIC EARNINGS PER SHARE:

NET LOSS PER SHARE                                                              $      (0.12)         $          ( 0.17)
                                                                                ==============          =================
NUMBER OF SHARES USED IN BASIC EARNINGS
     PER SHARE CALCULATIONS                                                           37,721                     38,380
                                                                                ==============            ===============
DILUTED EARNINGS PER SHARE:

NET LOSS PER SHARE                                                              $      (0.12)          $          (0.17)
                                                                                ================        =================
NUMBER OF SHARES USED IN DILUTED EARNINGS
     PER SHARE CALCULATIONS                                                           37,721                     38,380
                                                                                ================         ================
DIVIDENDS PER SHARE                                                             $       0.03            $          0.03
                                                                                ==================       =================
</TABLE>

The accompanying notes are an integral part of these statements.

<PAGE>

                  DELTA AND PINE LAND COMPANY AND SUBSIDIARIES
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                           FOR THE THREE MONTHS ENDED
                                 (in thousands)
                                   (Unaudited)

<TABLE>
<CAPTION>

                                                                                                   November 30,         November 30,
                                                                                                      1997                    1998
                                                                                                   ------------         ------------
<S>                                                                                                   <C>                   <C>    
CASH FLOWS FROM OPERATING ACTIVITIES:

Net loss                                                                                             $ (4,641)            $  (6,439)
Adjustments to reconcile net loss to net cash provided by
   (used in) operating activities:
     Depreciation and amortization                                                                      1,807                 1,668
     Minority interest in subsidiaries                                                                    158                 2,697
Changes in current assets and liabilities:
     Receivables                                                                                       84,437                91,533
     Inventories                                                                                      (25,561)              (42,014)
     Prepaid expenses                                                                                     289                (2,467)
     Accounts payable                                                                                  13,560                10,408
     Accrued expenses                                                                                 (79,421)              (63,328)
     Income taxes payable                                                                              (4,251)               (1,148)
Decrease in intangible and other assets                                                                    46                   139
                                                                                                      --------               -------
     Net cash used in operating activities                                                            (13,577)               (8,951)
                                                                                                      --------               -------
CASH FLOWS FROM INVESTING ACTIVITIES:
     Purchases of property and equipment                                                               (3,896)               (2,822)
     Proceeds from sale of investment                                                                   1,350                  --
                                                                                                      --------               -------
         Net cash used in investing activities                                                         (2,546)               (2,822)
                                                                                                      --------               -------
CASH FLOWS FROM FINANCING ACTIVITIES:
     Payments of short-term debt                                                                       (3,861)              (10,000)
     Payments of long-term debt                                                                       (35,092)                 --
     Dividends paid                                                                                    (1,159)               (1,176)
     Proceeds from long-term debt                                                                      40,634                 9,010
     Proceeds from short-term debt                                                                     15,597                10,000
     Proceeds from exercise of stock options and tax benefit
      of stock option exercises                                                                         2,784                   479
                                                                                                      --------               -------
         Net cash provided by financing activities                                                     18,903                 8,313
                                                                                                      --------               -------
EFFECTS OF FOREIGN CURRENCY TRANSLATION                                                                  (530)                1,023

NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS                                                    2,250                (2,437)
CASH AND CASH EQUIVALENTS, as of August 31                                                              1,890                 8,062
                                                                                                      --------               -------
CASH AND CASH EQUIVALENTS, as of November 30                                                         $  4,140              $  5,625
                                                                                                      ========               =======
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
     Cash paid during the three months for:
         Interest paid, net of capitalized interest                                                  $    325              $    550
         Income taxes                                                                                $     --              $    110
</TABLE>

The accompanying notes are an integral part of these statements.

<PAGE>


                  DELTA AND PINE LAND COMPANY AND SUBSIDIARIES
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
          (Amounts in thousands, except percentages and share amounts)

1.  BASIS OF PRESENTATION

The accompanying  unaudited consolidated financial statements have been prepared
in accordance  with the generally  accepted  accounting  principles  for interim
financial information and Article 10 of Regulation S-X. Accordingly, they do not
include all of the  information  and  footnotes  required by generally  accepted
accounting  principles  for  complete  financial  statements.  In the opinion of
management, all adjustments (consisting of normal recurring accruals) considered
necessary for the fair  presentation of the  consolidated  financial  statements
have been  included.  Due to the seasonal  nature of Delta and Pine Land Company
and subsidiaries'  (the "Company")  business,  the results of operations for the
three month  periods  ended  November  30, 1997 and November 30, 1998 or for any
quarterly period,  are not necessarily  indicative of the results to be expected
for the full  year.  For  further  information  reference  should be made to the
consolidated   financial  statements  and  footnotes  thereto  included  in  the
Company's  Annual Report to  Stockholders on Form 10-K for the fiscal year ended
August 31, 1998.

Certain  prior year balances  have been  reclassified  to conform to the current
year presentation.

2.   MERGER WITH MONSANTO

On May 8, 1998,  the  Company  entered  into a merger  agreement  with  Monsanto
Company  ("Monsanto"),  pursuant to which the  Company  would be merged with and
into Monsanto.  This agreement has been approved by the Company's  stockholders,
but is  still  subject  to  the  expiration  of the  waiting  period  under  the
Hart-Scott-Rodino  Antitrust  Improvements  Act of 1976.  Under the terms of the
agreement,  upon  consummation  the Company's  stockholders  will be entitled to
receive 0.8625 shares of Monsanto's Common Stock in exchange for each share of
Delta and Pine Land Company stock they hold.

3.   RECENT ACCOUNTING PRONOUNCEMENTS

SFAS No. 130, "Reporting  Comprehensive  Income",  establishes new standards for
reporting  comprehensive  income and its  components  in  financial  statements.
Comprehensive income, as defined,  includes all non-shareowner changes in equity
and consists of net income, foreign currency translation adjustments, unrealized
gains and losses on available-for-sale securities, and minimum pension liability
adjustments.  Effective  September 1, 1998,  the Company  adopted the  reporting
requirements  of SFAS No. 130. Total  comprehensive  income for the three months
ended November 30, 1997 and 1998 was (in thousands):

                                                       Three Months Ended
                                                          November 30,
                                                         1997        1998
                                                        -------     --------
Net (loss)                                             $(4,641)     $(6,439)
Other comprehensive (loss) income:
     Foreign currency translation (losses) and gains      (530)       1,023
     Income tax benefit (expense) related to 
          other comprehensive income                       196         (387)
                                                        -------     --------
     Other comprehensive (loss) income, net of tax        (334)         636 
                                                        -------     --------
Total comprehensive (loss) applicable to common
     stockholders                                      $(4,975)     $(5,803)
                                                        =======     ========

SFAS  No.  131,  "Disclosures  about  Segments  of  an  Enterprise  and  Related
Information," establishes standards for the way that public business enterprises
report information about operating  segments in annual financial  statements and
requires that those  enterprises  report  selected  information  about operating
segments in interim financial reports issued to shareholders.  This statement is
effective for financial  statements  for periods  beginning  after  December 15,
1997.  Management  of the  Company  has  determined  it is in only  one  line of
business, and therefore is not affected by this statement.




<PAGE>

SFAS No. 132,  "Employers'  Disclosures about Pensions and Other  Postretirement
Benefits," revises employers' disclosures about pension and other postretirement
benefit plans. It does not change the measurement or recognition of those plans.
This statement is effective for fiscal years  beginning after December 15, 1997.
The  Company  will adopt the year end  disclosure  requirements  of SFAS No. 132
beginning in fiscal 1999.

SFAS No. 133,  "Accounting for Derivative  Instruments and Hedging  Activities,"
establishes  accounting and reporting standards for the derivative  instruments,
including certain derivative  instruments  embedded in other contracts,  and for
hedging  activities.  This  statement  is effective  for all fiscal  quarters of
fiscal years  beginning  after June 15, 1999. The Company has not yet determined
the effects of adopting of SFAS No. 133 on its financial statements.

4.  INVENTORIES

Inventories consisted of the following (in thousands):


                               November 30,      August 31,       November 30,
                                     1997              1998             1998

Finished goods               $       35,787      $    45,121    $       60,434
Raw materials                        40,068           14,036            34,519
Growing crops                           109              586               493
Supplies and other                    1,252              676               688
                           ----------------   -------------- -----------------
                                     77,216           60,419            96,134
Less reserves                        (2,620)          (9,922)           (3,623)
                           -----------------   --------------  ----------------
                            $        74,596     $     50,497    $       92,511
                            ===============     ============    ==============

Substantially  all finished  goods and raw  material  inventory is valued at the
lower of average cost or market. Growing crops are recorded at cost.


5.  PROPERTY, PLANT AND EQUIPMENT

Property, plant and equipment consisted of the following (in thousands):


                               November 30,  August 31, November 30,
                                  1997        1998         1998

Land and improvements           $  4,419    $  4,437    $  4,564
Buildings and improvements        33,755      35,849      36,750
Machinery and equipment           36,569      38,530      43,172
Germplasm                          7,500       7,500       7,500
Breeder and foundation seed        2,000       2,000       2,000
Construction in progress           6,608       5,650       2,950
                                 -------    --------    --------
                                  90,851      93,966      96,936
Less accumulated depreciation    (25,740)    (27,126)    (28,908)
                                --------    --------    --------
                                $ 65,111    $ 66,840    $ 68,028
                                ========    ========    ========

6.  CONTINGENCIES

The Company,  Monsanto and other third  parties were named as  defendants in (i)
one lawsuit filed on November 30, 1998, in the Superior  Court of Brooks County,
Georgia;  (ii) one lawsuit filed on December 11, 1998, in the Superior  Court of
Lowndes  County,  Georgia,  (iii) 5 lawsuits filed on December 15, 1998, in the
Superior Court of Brooks County,  Georgia; (iv) 3 lawsuits filed on December 23,
1998 in the Superior Court of Brooks County,  Georgia; and (v) 2 lawsuits filed
on  December  31,  1998,  in the  Superior  Court  of  Brooks  County,  Georgia.
Subsequent  to the dates these  lawsuits  were filed,  9 have been removed and 3
will be removed to the U.S.  District Court for the Middle  District of Georgia.
In each case the plaintiff alleges,  among other things, that certain cottonseed
acquired  from  Paymaster  which  contained  the Roundup  Ready (R) gene did not
perform as the farmers had anticipated and, in particular, did not fully protect
their crops from damage following the application of Roundup glyphosate.

This litigation is identical to one of the seed arbitrations  filed in the State
of Georgia.  The Company and Monsanto are presently  investigating the claims to
determine the cause or causes of the alleged problems.  Pursuant to the terms of
the Roundup Ready Gene License and Seed Service  Agreement  (the "Roundup  Ready
Agreement")  between D&PL and  Monsanto,  D&PL has tendered the defense of these
claims to  Monsanto.  Pursuant  to the  Roundup  Ready  Agreement,  Monsanto  is
contractually  obligated to defend and indemnify the Company  against all claims
arising out of the failure of the Roundup  glyphosate  tolerance gene. D&PL will
not  have a right to  indemnification  from  Monsanto,  however,  for any  claim
involving defective varietal characteristics separate from or in addition to the
failure of the  herbicide  tolerance  gene.  Such claims are  contained in these
complaints.  D&PL  believes  that these  claims  will be  resolved  without  any
material impact on the Company's financial statements.

Through  December 31,  1998,  45 farmers in  Mississippi  and 9 farmers in Texas
filed arbitration claims against the Company and Monsanto with state agencies in
Mississippi  and Texas.  The  complainants  allege that  Roundup  Ready (R) seed
marketed by the Company failed to perform as  anticipated  resulting in deformed
or missing bolls and some further assert  substantial yield losses in their 1998
crops.  The Company and Monsanto  are  presently  investigating  these claims to
determine the cause or causes of the problems alleged.  Pursuant to the terms of
the Roundup  Ready  Agreement  between D&PL and  Monsanto,  Monsanto has assumed
responsibility  for the defense of these  claims.  Pursuant to the Roundup Ready
Agreement,  Monsanto is  contractually  obligated  to defend and  indemnify  the
Company  against  all  claims  arising  out  of  failure  of the  Roundup  Ready
glyphosate  tolerance gene. D&PL will not have a right to  indemnification  from
Monsanto,  however, for any claims involving defective varietal  characteristics
separate from or in addition to failure of the  herbicide-tolerance  gene.  D&PL
believes that these claims will be resolved  without any material  impact on the
Company's financial statements.

<PAGE>


Through December 31, 1998, 199 farmers in Georgia have filed arbitration  claims
against the Company and, in some cases, Monsanto. The original complaints in the
cases allege that certain  Roundup Ready  Paymaster  cotton seed marketed by the
Company in 1998 produced plants which exhibited a condition known as Bronze Wilt
and consequently  sustained  varying degrees of lost yield. Some complaints also
contain allegations of poor germination. Approximately 80 of the complaints were
recently amended to allege that Roundup  applications caused extensive boll shed
and other problems with these cotton crops. Pursuant to the terms of the Roundup
Ready  Agreement  between  D&PL and  Monsanto,  D&PL has tendered the defense of
these claims to Monsanto.  Pursuant to the Roundup Ready Agreement,  Monsanto is
contractually  obligated to defend and indemnify the Company  against all claims
arising out of the failure of the Roundup  glyphosate  tolerance gene. D&PL will
not  have a right to  indemnification  from  Monsanto,  however,  for any  claim
involving defective varietal characteristics separate from or in addition to the
failure  of the  herbicide  tolerance  gene.  D&PL and  Monsanto  are  currently
investigating  these  claims to  determine  the  cause or causes of the  alleged
problems and are working cooperatively with the respective states departments of
agriculture to gather the necessary  information regarding causation and damage.
Presently, the definitive causes of the alleged Bronze Wilt and poor germination
in this seed have not been established,  and accordingly,  Monsanto's  indemnity
obligation,  if any, is unresolved.  It is D&PL's intention to defend vigorously
claims  asserting  product  defects in the varieties.  Management  believes that
these  complaints will be resolved  without any material impact on the Company's
consolidated financial statements.

The  Company,  certain  subsidiaries  of  Monsanto  and  others  were  named  as
defendants in a lawsuit filed in the Civil District  Court,  Williamson  County,
Texas,  277th Judicial  District,  in April 1997. The plaintiffs  allege,  among
others  things,  that certain  cottonseed  acquired  from  Monsanto in the Hartz
Cotton  acquisition  and  subsequently  sold by the Company failed to perform as
represented  allegedly  resulting in lost yield. The Company has filed a Summary
Judgment motion based on failure to arbitrate in accordance with Texas seed law.
Pursuant to the Hartz Cotton Acquisition  agreement,  the Company is entitled to
indemnification from Monsanto for damages resulting from the sale of bagged seed
inventories  acquired  by  D&PL  in that  acquisition.  Some or all of the  seed
involved in this case may meet this criteria and D&PL will therefore be entitled
to  indemnification  from  Monsanto  for any  losses  resulting  from such seed.
Management  believes that this case will be resolved without any material impact
on the Company's financial statements.

The  Company,  Monsanto  and other third  parties  were named as  defendants  in
lawsuits filed in (i) the District Court of Falls County,  Texas, in August 1996
and (ii) in the District Court of Robertson  County,  Texas,  in March 1998. The
plaintiffs allege, among other things, that D&PL's cottonseed  varieties,  which
contain Monsanto's Bollgard gene, did not perform as the farmers had anticipated
and, in  particular,  did not fully  protect  their  cotton  crops from  certain
lepidopteran  insects.  Pursuant to the terms of the Bollgard  Agreement between
D&PL and Monsanto,  Monsanto has assumed responsibility for the defense of these
claims.  The portion of this claim  relating to failure of the Bollgard  gene is
subject to a duty of defense by Monsanto and prorata  indemnification  under the
Bollgard Agreement.  Under the applicable  indemnity  provisions of the Bollgard
Agreement,  defense costs and liability to the  plaintiffs on any failure of the
technology  would be  apportioned  71% to Monsanto and 29% to D&PL.  Some of the
claims in this  litigation  concern  failure of  Monsanto's  express  warranties
relating to insect  resistance  and those  claims may not be within the scope of
D&PL's partial indemnity obligation to Monsanto.  On the other hand, some of the
claims  made in the  litigation  concern  the  quality  of seed  and  seed  coat
treatments,  or other  varietal  aspects of variety,  not  involving  failure of
performance of the Bollgard gene or express representations with respect thereto
and, therefore,  may not be within the scope of Monsanto's  indemnity obligation
to D&PL.  D&PL intends to cooperate  with Monsanto in its  anticipated  vigorous
defense of these suits.  D&PL believes that these suits will be resolved without
any material impact on the Company's consolidated financial statements.

<PAGE>

In  October  1996,   Mycogen  Plant  Science,   Inc.  and   Agrigenetics,   Inc.
(collectively  "Mycogen")  filed a lawsuit in U.S.  District  Court in  Delaware
naming D&PL,  Monsanto and DeKalb  Genetics as  defendants  alleging that two of
Mycogen's  recently  issued  patents have been  infringed by the  defendants  by
making,  selling,  and licensing  seed that contains the Bollgard gene. The suit
which  went  to  trial  in  January  1998  sought  injunctions  against  alleged
infringement, compensatory damages, treble damages and attorney's fees and court
costs.  A jury found in favor of D&PL and  Monsanto  on issues of  infringement.
Mycogen has subsequently re-filed a motion for a new trial and for a judgment in
favor of  Mycogen  as a matter of law.  Pursuant  to the  terms of the  Bollgard
Agreement,  Monsanto  is required to defend  D&PL  against  patent  infringement
claims and indemnify D&PL against  damages from any patent  infringement  claims
and certain other losses and costs.  Due to  Monsanto's  obligation to indemnify
D&PL,  the Company  believes that the  resolution of this matter will not have a
material impact on the Company or its financial statements.

In  May  1998,  five  individual  alleged  shareholders  brought  suits  against
Monsanto,  the Company and its Board of Directors  ("Directors") in the Court of
Chancery  in New  Castle  County,  Delaware.  The  complaints  alleged  that the
consideration  to be paid in the proposed merger of the Company with Monsanto is
inadequate and that the Company's  Directors  breached their fiduciary duties to
the  Company's  stockholders  by voting to  approve  the  Agreement  and Plan of
Merger,  and that  Monsanto  aided and abetted the alleged  breach of  fiduciary
duty.  The  complaints  were  consolidated  into  one  action,  which  sought  a
declaration that the action was maintainable as a class action,  that the merger
be  enjoined,  or  alternatively,  rescinded,  and/or  an award  of  unspecified
compensatory damages if the merger was consummated.  The claims set forth in the
complaints were settled in November 1998, and the parties intend to apply to the
Court for a date for a hearing on the settlement that they have reached.

<PAGE>

A corporation  owned by the son of the Company's former  Guatemalan  distributor
sued in 1989  asserting  that  the  Company  violated  an  agreement  with it by
granting  to another  entity an  exclusive  license in certain  areas of Central
America and southern  Mexico.  The suit seeks  damages of  5,300,000  Guatemalan
quetzales  (approximately  $800,000 at current exchange rates) and an injunction
preventing the Company from distributing seed through any other licensee in that
region.  The  Guatemalan  court,  where  this  action is  proceeding,  has twice
declined  to  approve  the  injunction  sought.  Management  believes  that  the
resolution of the matter will not a have  material  impact on the Company or its
financial statements. The Company continues to offer seed for sale in Guatemala.

The Company is involved in various other claims  arising in the normal course of
business. Management believes such matters will be resolved without any material
effect on the Company's financial position or its results of operations.

On July 18, 1996, the United States  Department of Justice,  Antitrust  Division
("USDOJ"),   served  a  Civil  Investigative  Demand  ("CID")  on  D&PL  seeking
information  and  documents  in  connection  with  its   investigation   of  the
acquisition  by D&PL of the stock of Arizona  Processing,  Inc.,  Ellis Brothers
Seed, Inc. and Mississippi Seed, Inc. (which own the outstanding common stock of
Sure Grow Seed,  Inc).  The CID states that the USDOJ is  investigating  whether
these  transactions may have violated the provisions of Section 7 of the Clayton
Act, 15 USC ss. 18. D&PL has responded to the CID,  employees have been examined
by the USDOJ,  and D&PL is committed to full  cooperation with the USDOJ. At the
present time, the ultimate outcome of the investigation cannot be predicted.

7.    EARNINGS PER SHARE

The table below reconciles basic and diluted earnings per share at November 30:
 
 Basic:                                                     1997          1998
                                                    
 Net loss                                                $ (4,641)     $ (6,439)
 Preferred stock dividends                                    (24)          (24)
                                                         ---------     ---------
 Net loss applicable to common  stockholders             $ (4,665)     $ (6,463)
                                                         =========     =========
 Weighted average shares outstanding                       37,721        38,380 
                                                         =========     =========
  Basic earnings per share                               $  (0.12)     $  (0.17)
                                                         =========     =========

Diluted:
Net loss applicable to common stockholders               $ (4,665)     $ (6,463)
Add Back:
 Preferred stock dividends                                     24            24
                                                         ----------    ---------
Net loss applicable to
    common stockholders                                  $ (4,665)     $ (6,439)
                                                         ==========    =========
  Weighted average shares outstanding                      37,721        38,380
                                                         ----------    ---------
  Diluted shares outstanding                               37,721        38,380
                                                         ==========    =========
  Diluted earnings per share                             $  (0.12)     $  (0.17)
                                                         ==========    =========
<PAGE>

ITEM 2.   MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
                 RESULTS OF OPERATIONS

Overview

On May 8,  1998,  Delta and Pine  Land  Company  and  subsidiaries,  a  Delaware
Corporation  ("D&PL" or the  "Company")  entered  into a merger  agreement  with
Monsanto  Company  ("Monsanto"),  pursuant to which the Company  would be merged
with and into  Monsanto.  This  agreement  has been  approved  by the  Company's
stockholders  but is subject to the  expiration of the waiting  period under the
Hart-Scott-Rodino  Antitrust  Improvements  Act  of  1976.  Under  terms  of the
agreement,  upon  consummation  the Company's  stockholders  will be entitled to
receive  0.8625 shares of Monsanto's  Common Stock in exchange for each share of
Delta and Pine Land stock they hold.

On June 1,  1998,  Monsanto  and  American  Home  Products  Corporation  ("AHP")
announced  that they had entered into an agreement  providing  for the merger of
those two companies.  On October 13, 1998, AHP and Monsanto  announced  publicly
that they had mutually agreed to terminate the merger pursuant to the agreement.

D&PL  is  primarily  engaged  in  the  breeding,  production,  conditioning  and
marketing of proprietary  varieties of cotton planting seed in the United States
and other cotton producing nations. D&PL also breeds,  produces,  conditions and
distributes soybean planting seed in the United States.

Since 1915, D&PL has bred,  produced and/or marketed upland picker  varieties of
cotton planting seed for cotton varieties that are grown primarily east of Texas
and in Arizona.  The Company has used its  extensive  classical  plant  breeding
programs to develop a gene pool  necessary for producing  cotton  varieties with
improved  agronomic  traits  important  to farmers,  such as crop yield,  and to
textile  manufacturers,  such as enhanced fiber  characteristics.  In 1996, D&PL
commenced  commercial  sales  in the  United  States  of  cotton  planting  seed
containing Bollgard(TM) gene technology licensed from Monsanto which expresses a
protein  toxic to  certain  lepidopteran  cotton  pests.  Since  1997,  D&PL has
marketed  in the  U.S.  genetically  modified  cotton  planting  seed  providing
tolerance to glyphosate-based herbicides ("Roundup Ready(R) Cotton").

In 1980,  D&PL added soybean seed and in 1988 hybrid sorghum seed to its product
line.  In 1988,  D&PL also  commenced  distributing  corn hybrids  acquired from
others. In 1995, the Company sold its corn and sorghum business to Mycogen Plant
Science,  Inc.  ("Mycogen").

During the 1980's, as a component of its long-term growth strategy,  the Company
began to market its  products,  primarily  cottonseed,  internationally.  Over a
period of years,  the Company has  strengthened  and expanded its  international
staff in order to support its  expanding  joint venture  activities.  In foreign
countries,  cotton acreage is often planted with farmer-saved seed which has not
been delinted or treated and is of low overall quality. Management believes that
D&PL has an attractive  opportunity to penetrate  foreign markets because of its
widely adaptable, superior cotton varieties, technological know-how in producing
and conditioning high-quality seed and brand name recognition.  Furthermore,  in
many countries the Bollgard gene  technology  and Roundup Ready gene  technology
licensed from Monsanto would be effective and help farmers in those countries.

D&PL sells its products in foreign  countries  through (i) export sales from the
U.S.,  (ii)  direct   in-country   operations  and  to  a  lesser  degree  (iii)
distributors  or licensees.  The method varies and evolves,  depending  upon the
Company's  assessment of the  potential  size and  profitability  of the market,
governmental policies,  currency and credit risks,  sophistication of the target
country's  agricultural  economy, and costs (as compared to risks) of commencing
physical  operations  in a  particular  country.  To  date,  a  majority  of the
Company's  international  sales have  resulted from exports from the U.S. of the
Company's products rather than direct in-country operations.

In 1997,  D&PL  announced a production  and cost  optimization  program aimed to
improve operating efficiencies. As part of this program, the Company idled three
of its delinting  facilities and reduced its work force at these  facilities and
at other locations by offering  eligible  employees a voluntary early retirement
plan. D&PL believes its reconfigured  production  capabilities  will allow it to
continue to meet the accelerating  demand for its insect resistant and herbicide
tolerant transgenic products on a cost efficient basis to the farmer.

Acquisitions

In 1996, D&PL acquired Ellis Brothers Seed, Inc., Arizona  Processing,  Inc. and
Mississippi  Seed,  Inc.,  which own the  outstanding  common stock of Sure Grow
Seed,  Inc.,  (the  "Sure  Grow  Companies")  in  exchange  for stock  valued at
approximately  $70 million on the day of  closing.  D&PL  exchanged  2.8 million
shares of its common stock (after all stock splits) for all  outstanding  shares
of the three companies.  The merger was accounted for as a pooling-of-interests.
The Company  continues to market upland picker  cottonseed  varieties  under the
Sure Grow brand. Additionally, the Sure Grow breeding program has full access to
Monsanto's Bollgard and Roundup Ready gene technologies.

In 1996, the Company acquired Hartz Cotton,  Inc. from Monsanto,  which included
inventories of cotton planting seed of Hartz upland picker varieties, germplasm,
breeding stocks,  trademarks,  trade names and other assets,  for  approximately
$6.0 million. The consideration consisted primarily of 800,000 shares (after all
stock splits) of the Company's Series M Convertible  NonVoting  Preferred Stock.
Additional  shares  may  be  issued  to  Monsanto  depending  on the  sales  and
profitability levels achieved by the product line acquired.


<PAGE>

Since the 1940's,  the  Paymaster(R) and Lankart(R)  upland stripper  cottonseed
varieties have been  developed for and marketed  primarily in the High Plains of
Texas and Oklahoma (the "High Plains"). In 1994, D&PL acquired the Paymaster and
Lankart cotton planting seed business  ("Paymaster"),  for  approximately  $14.0
million.  Although the Paymaster  varieties are planted on approximately  80% of
the estimated 4.0 to 5.0 million cotton acres in the High Plains, only a portion
of that seed is actually  sold by  Paymaster.  Farmer-saved  seed accounts for a
significant portion of the seed needed to plant the acreage in this market area.
Through  1996 the  seed  needed  to  plant  the  remaining  acreage  was sold by
Paymaster and its 12 sales  associates  through a certified seed program.  Under
this program,  Paymaster  sold parent seed to its contract  growers who planted,
produced and  harvested  the progeny of the parent seed,  which  Paymaster  then
purchased  from the  growers.  The  progeny of the parent  seed was then sold by
Paymaster to the sales associates who in turn delinted,  conditioned, bagged and
sold it to others as  certified  seed.  The sales  associates  paid a royalty to
Paymaster on certified seed sales.  Beginning in fiscal 1997,  D&PL's operations
department,   in  addition  to  producing  parent  seed,   commenced  delinting,
conditioning and bagging finished seed.  Unconditioned  seed is also supplied by
D&PL to a limited number of contract  processors  who delint,  condition and bag
seed for a fee.  This  finished  seed is sold by Paymaster to  distributors  and
dealers.

The Company acquired in 1994 from the Supima  Association of America  ("Supima")
certain  planting seed inventory,  the right to use the Supima(R) trade name and
trademark  and the right to distribute  Pima  extra-long  staple  (fiber-length)
cotton  varieties.  D&PL also entered into a research  agreement  with  Supima's
university collaborator that allows D&PL the right of first refusal for any Pima
varieties  developed under this program which D&PL partially funds. In 1998 D&PL
gave notice to its  university  collaborator  of its intention to terminate this
agreement and entered into an agreement  with a third party to conduct  research
on Pima cotton varieties. Pima seed is produced, conditioned and sold by D&PL to
distributors and dealers.

Biotechnology

Collaborative  biotechnology  licensing  agreements  which  were  executed  with
Monsanto  in 1992 and  subsequently  revised in 1993 and 1996,  provide  for the
commercialization of Monsanto's Bollgard ("Bacillus thuringiensis" or "Bt") gene
technology in D&PL's  varieties.  The selected Bt is a bacterium found naturally
in soil  and  produces  proteins  toxic  to  certain  lepidopteran  larvae,  the
principal  cotton  pests  in many  cotton  growing  areas.  Monsanto  created  a
transgenic  cotton plant by inserting  Bt genes into cotton plant  tissue.  This
transgenic  plant tissue is lethal to certain  lepidopteran  larvae that consume
it. The gene and related  technology  were  patented or licensed  from others by
Monsanto  and were  licensed to D&PL for use under the trade name  Bollgard.  In
D&PL's  primary  markets,  the  cost  of  insecticides  is  the  largest  single
expenditure  for many  cotton  growers.  The insect  resistant  capabilities  of
transgenic  cotton  containing  the  Bollgard  gene may  reduce  the  amount  of
insecticide  required  to be  applied  by cotton  growers  using  planting  seed
containing  the Bollgard  gene. In October 1995,  Monsanto was notified that the
United States Environmental  Protection Agency ("EPA") had completed its initial
registration  of the  Bollgard  gene  technology,  thus  clearing  the  way  for
commercial  sales of seed  containing  the  Bollgard  gene.  In 1996,  D&PL sold
commercially  for the first time two Delta Pine  varieties,  which contained the
Bollgard  gene,  in  accordance  with the terms of the Bollgard Gene License and
Seed  Services  Agreement  (the  "Bollgard  Agreement")  between the Company and
Monsanto.  This initial EPA  registration  expires on January 1, 2001,  at which
time the EPA will,  among other  things,  reevaluate  the  effectiveness  of the
insect resistance management plan and decide whether to convert the registration
to a non-expiring (and/or unconditional) registration.

<PAGE>

Pursuant to the terms of the Bollgard Agreement,  farmers must buy a limited use
sub-license  for the  technology  from D&M Partners,  a partnership  of D&PL and
Monsanto,  in order to purchase  seed  containing  the Bt gene  technology.  The
distributor/dealers  who  coordinate  the  farmer  licensing  process  receive a
service payment not to exceed 20% of the technology sub-licensing fee. After the
dealers and distributors  are compensated,  D&M Partners pays Monsanto a royalty
equal to 71% of the net  sub-license  fee  (technology  sub-licensing  fees less
distributor/dealer payments) and D&PL receives 29% for its services. The license
agreement  continues  until the later of the  expiration of all patent rights or
October 2008.

Pursuant to the Bollgard  Agreement,  Monsanto  must defend and  indemnify  D&PL
against claims of patent infringement,  including all damages awarded or amounts
paid in  settlements.  Monsanto  must also  indemnify  D&PL  against a) costs of
inventory and b) lost profits on inventory which becomes  unsaleable  because of
patent  infringement  claims.  Monsanto  must  defend  any  claims of failure of
performance of a Bollgard gene.  Monsanto and D&PL share the cost of any product
performance claims in proportion to each party's share of the royalty. Indemnity
from  Monsanto  only  covers  performance  claims  involving  failure  of insect
resistance, and not claims arising from other causes.

D&PL has also developed  transgenic cotton and transgenic soybean varieties that
are tolerant to Roundup, a glyphosate-based herbicide sold by Monsanto. In 1996,
such Roundup Ready plants were approved by the Food and Drug Administration, the
USDA,  and the EPA. In February  1996,  the Company and  Monsanto  executed  the
Roundup  Ready Gene License and Seed  Services  Agreement  (the  "Roundup  Ready
Agreement")   which  provides  for  the   commercialization   of  Roundup  Ready
cottonseed.  The Roundup Ready Agreement grants a license to D&PL and certain of
its  affiliates  the right in the  United  States to sell  cottonseed  of D&PL's
varieties  that contain  Monsanto's  Roundup Ready gene.  The Roundup Ready gene
makes cotton plants tolerant to contact with Roundup  herbicide.  Similar to the
Bollgard  Agreement,  farmers  must  execute  limited  use  sublicenses  for the
technology in order to purchase seed containing the Roundup Ready Gene. Monsanto
must defend and indemnify D&PL against claims of patent infringement,  including
all damages awarded or amounts paid in settlements. Monsanto will also indemnify
D&PL against the cost of inventory  that  becomes  unsaleable  because of patent
infringement claims, but Monsanto is not required to indemnify D&PL against lost
profits on such  unsaleable  seed.  In contrast  with the Bollgard  Gene License
where the costs of gene  performance  claims will be shared in proportion to the
division of  sub-license  revenue,  Monsanto  must defend and must bear the full
cost of any claims of failure of  performance of the Roundup Ready Gene. In both
agreements,  generally, D&PL is responsible for varietal/seed performance issues
and Monsanto is  responsible  for failure of the genes.  In February  1997,  the
Company and Monsanto  executed the Roundup Ready Soybean License  Agreement (the
"Roundup Ready Soybean Agreement") which provides for the  commercialization  of
Roundup  Ready  soybean  seed and has  provisions  similar to the Roundup  Ready
Agreement for cottonseed.

<PAGE>


Since  1987,  D&PL has  conducted  research  using  genes  provided by DuPont to
develop  soybean plants that are tolerant to certain  DuPont ALS(R)  herbicides.
Such plants enable farmers to apply these  herbicides  for weed control  without
significantly affecting the agronomics of the soybean plants. Since soybean seed
containing the ALS herbicide-tolerant trait was not genetically engineered, sale
of this seed does not require  government  approval,  although the  herbicide to
which they express tolerance must be EPA approved.

D&PL  announced  in March  1998 that it was  granted  United  States  Patent No.
5,723,765,  entitled  CONTROL OF PLANT  GENE  EXPRESSION.  This  patent is owned
jointly  by D&PL  and the  United  States  of  America,  as  represented  by the
Secretary  of  Agriculture.  The patent  broadly  covers  plants and seed,  both
transgenic  and  conventional,  of all  species  for a system  designed to allow
control of progeny  seed  viability  without  harming  the crop.  The  principal
application of the technology will be to control  unauthorized  planting of seed
of  proprietary  varieties  (sometimes  called  "brown  bagging") by making such
practice  non-economic  since  unauthorized  saved seed will not germinate,  and
would  be  useless  for  planting.  The  patent  has  the  prospect  of  opening
significant  worldwide  seed  markets to the sale of  transgenic  technology  in
varietal  crops in which  crop seed  currently  is saved and used in  subsequent
seasons as planting seed. D&PL intends that licensing of this technology will be
made widely available to other seed companies and intends for it to be used only
in those varieties that contain transgenic traits.

The patent  was  developed  from a  research  program  conducted  pursuant  to a
Cooperative  Research  and  Development  Agreement  between  D&PL  and the  U.S.
Department of Agriculture's Agricultural Research Service in Lubbock, Texas. The
technology  resulted from basic research and will require  further  development,
which is already  underway,  in order to be used in commercial seed. The Company
estimates  that  it may  be as  many  as  seven  years  before  this  Technology
Protection System ("TPS") could be available commercially.

The Company has license, research and development,  confidentiality and material
transfer  agreements with providers of technology that the Company is evaluating
for potential  commercial  applications  and/or  introduction.  The Company also
contracts  with third parties to perform  research on the  Company's  behalf for
enabling  and  other  technologies  that the  Company  believes  have  potential
commercial applications in varietal crops around the world.

<PAGE>


 Commercial Seed

Seed of all commercial plant species is either varietal or hybrid. D&PL's cotton
and soybean seed are  varietals.  Varietal  plants can be  reproduced  from seed
produced by a parent  plant,  with the offspring  exhibiting  only minor genetic
variations.  The Plant  Variety  Protection  Act of 1970, as amended in 1994, in
essence prohibits,  with limited  exceptions,  purchasers of varieties protected
under the amended Act from selling seed harvested from these  varieties  without
permission  of the plant  variety  protection  certificate  owner.  Some foreign
countries provide similar legal protection for breeders of crop varieties.

Although  cotton is varietal  and,  therefore,  can be grown from seed of parent
plants saved by the growers,  most farmers in D&PL's  primary  domestic  markets
purchase seed from commercial  sources each season because  cottonseed  requires
delinting  in order  to be sown by  modern  planting  equipment.  Delinting  and
conditioning  may be done either by a seed company on its proprietary seed or by
independent delinters for farmers.  Modern cotton farmers in upland picker areas
generally  recognize  the  greater  assurance  of genetic  purity,  quality  and
convenience  that  professionally  grown and conditioned seed offers compared to
seed they might save.

In connection  with its seed  operations,  the Company also farms  approximately
2,600  acres in the  U.S.,  primarily  for  production  of  cotton  and  soybean
foundation  seed.  The Company has annual  agreements  with  various  growers to
produce seed for cotton and soybeans.  The growers  plant parent seed  purchased
from the Company  and follow  quality  assurance  procedures  required  for seed
production.  If the grower  adheres to  established  Company  quality  assurance
standards  throughout the growing season and if the seed meets Company standards
upon  harvest,  the  Company may be  obligated  to  purchase  specified  minimum
quantities of seed,  usually in its first and second fiscal quarters,  at prices
equal to the  commodity  market  price of the seed  plus a grower  premium.  The
Company then conditions the seed for sale.

The  majority of the  Company's  sales are made from early in the second  fiscal
quarter  through the beginning of the fourth fiscal  quarter.  Varying  climatic
conditions can change the quarter in which seed is delivered,  thereby  shifting
sales and the  Company's  earnings  between  quarters.  Thus,  seed  production,
distribution  and sales are seasonal and interim results will not necessarily be
indicative of the Company's results for a fiscal year.

Revenues from domestic seed sales are generally recognized when seed is shipped.
Revenues from Bollgard and Roundup Ready licensing fees are recognized  based on
the  number  of acres  expected  to be  planted  with such seed when the seed is
shipped.  Prior to 1998,  licensing  fees were based on the estimated  number of
acres that  farmers  represented  would be planted with the seed  purchased.  In
1998, the licensing fee charged to farmers was based on pre-established planting
rates for seven geographic  regions.  Revenue is recognized based on established
technology fee per unit shipped to each  geographic  region.  Domestically,  the
Company  promotes its cotton and soybean seed  directly to farmers and sells its
seed  through  distributors  and dealers.  All of the  Company's  domestic  seed
products  (including  Bollgard and Roundup  Ready  technologies)  are subject to
return or credit, which vary from year to year. The annual level of returns and,
ultimately,  net sales are influenced by various factors,  principally commodity
prices and weather conditions occurring in the spring planting season during the
Company's third and fourth quarters.  The Company provides for estimated returns
as sales occur. To the extent actual returns differ from estimates,  adjustments
to the Company's  operating  results are recorded when such  differences  become
known,  typically in the Company's fourth quarter. All significant returns occur
or are accounted for by fiscal year end.  International export seed revenues are
recognized  upon the date seed is  shipped  or the date  letters  of credit  are
cleared,  whichever  is later.  Generally,  international  export  sales are not
subject to return.

<PAGE>


Year 2000 Readiness Disclosure

Beginning in 1996,  D&PL  initiated  its Global Year 2000 program to ensure that
its infrastructure and information systems comply with the systems  requirements
for the year 2000.  The  program  includes  the  following  phases:  identifying
systems  that need to be  replaced  or fixed;  assessing  the extent of the work
required;  prioritizing  the work;  and  successfully  completing the associated
action plans. In higher risk areas,  the Company also has developed  contingency
action  plans.  D&PL has  essentially  completed  the first three  phases of the
program  and is now  primarily  in the  implementation  phase.  Some  additional
identification and assessment  continues for recent acquisitions and in the area
of embedded  systems.  The majority of systems,  including all business critical
systems, are expected to comply with year 2000 requirements by the first quarter
of 1999 due in large part to the  installation  in fiscal  1997 of a third party
software  system,  at a cost in  excess  of  $3.0  million,  that  is year  2000
compliant. The Company continues to evaluate the estimated costs associated with
year 2000  compliance  based on actual  experience.  While the year 2000 efforts
involve additional costs, D&PL believes, based on available information, that it
will be able to manage its year 2000  transition  without any  material  adverse
effect on its business operations or financial position. Total costs incurred to
date for year 2000 considerations  (excluding third party software)  approximate
$0.2 million and the Company  estimates  that it might cost an  additional  $0.5
million to complete the year 2000 compliance process.

D&PL also has contacted its major suppliers to assess their preparations for the
year 2000. Similar contacts also are planned for major customers.  These actions
are taken to help  mitigate  the possible  external  impact of year 2000 issues.
Even so, presently it is not feasible to fully assess the potential consequences
if service interruptions occur from suppliers or in such infrastructure areas as
utilities,  communications,  transportation,  banking  and  government.  D&PL is
developing  business  continuity  plans to minimize the impact of such  external
events.

<PAGE>


Outlook

From time to time, the Company may make  forward-looking  statements relating to
such matters as anticipated financial performance,  existing products, technical
developments,  new  products,  research and  development  activities,  year 2000
issues and similar matters. The Private Securities Litigation Reform Act of 1995
provides a safe harbor for forward-looking  statements.  In order to comply with
the terms of the safe harbor,  the Company notes that a variety of factors could
cause the Company's actual results and experience to differ  materially from the
anticipated   results  or  other   expectations   expressed  in  the   Company's
forward-looking  statements.  The risks and  uncertainties  that may  affect the
operations,  performance,  development  and  results of the  Company's  business
include those noted elsewhere in this Item and the following:

     D&PL's  contemplated  merger  with  Monsanto  is  subject  to  approval  by
     government  agencies.  The  inability  to  complete  this merger may have a
     material effect on the Company.  However, such effect can not be determined
     at this time.

     Demand for D&PL's seed will be affected by  government  programs  and, most
     importantly,  by weather.  Demand for seed is also  influenced by commodity
     prices and the demand for a crop's end-uses such as textiles,  animal feed,
     food and raw  materials  for  industrial  use.  These  factors,  along with
     weather,  influence  the  cost  and  availability  of seed  for  subsequent
     seasons.  Weather  impacts crop yields,  commodity  prices and the planting
     decisions that farmers make regarding  both original  planting  commitments
     and, when necessary, replanting levels.

     The planting  seed market is highly  competitive  and D&PL  varieties  face
     competition  from  a  number  of  seed  companies,   diversified   chemical
     companies,  agricultural biotechnology companies, governmental agencies and
     academic   and   scientific   institutions.   A  number  of  chemical   and
     biotechnology   companies   have  seed   production   and/or   distribution
     capabilities  to ensure market access for new seed products.  The Company's
     seed  products may encounter  substantial  competition  from  technological
     advances  by others  or  products  from new  market  entrants.  Many of the
     Company's  competitors  are,  or are  affiliated  with,  large  diversified
     companies that have substantially greater resources than the Company.

     The production,  distribution or sale of crop seed in or to foreign markets
     may  be  subject  to  special  risks,  including  fluctuations  in  foreign
     currency, exchange rate controls, expropriation,  nationalization and other
     agricultural, economic, tax and regulatory policies of foreign governments.
     Particular  policies which may affect the international  operations of D&PL
     include the testing and quarantine and other  restrictions  relating to the
     import and export of plants and seed products and the availability (or lack
     thereof) of proprietary protection for plant products. In addition,  United
     States government policies,  particularly those affecting foreign trade and
     investment, may impact the Company's international operations.

     Due to the varying  levels of  agricultural  and social  development of the
     international  markets in which the Company operates and because of factors
     within  the  particular  international  markets  targeted  by the  Company,
     international  profitability  and growth may be less stable and predictable
     than domestic profitability and growth have been in the past.

     Overall  profitability  will  depend  on  weather  conditions,   government
     policies in all countries  where the Company  sells  products and operates,
     worldwide  commodity prices, the Company's ability to successfully open new
     international  markets, the Company's ability to successfully  continue the
     development of the High Plains market, the technology  partners' ability to
     obtain timely government approval (and maintain such approval) for existing
     and for additional biotechnology products on which they and the Company are
     working  and  the  Company's  ability  to  produce  sufficient   commercial
     quantities of high quality planting seed of these products. Any delay in or
     inability  to  successfully  complete  these  projects  may  affect  future
     profitability.


<PAGE>

RESULTS OF OPERATIONS

The following sets forth selected operating data of the Company (in thousands):

                                                      For the Three Months Ended
                                                       November 30, November 30,
                                                           1997            1998
                                                         ---------      --------
Operating results -
Net sales and licensing fees                             $  5,340      $  7,195
Gross profit                                                2,067         2,248
Operating expenses:
     Research and development                               3,632         4,235
     Selling                                                2,876         3,829
     General and administrative                             2,602         2,960
     Unusual charges related to acquisitions                   47           818
Operating loss                                             (7,090)       (9,594)
Loss before income taxes                                   (7,367)      (10,362)
Net loss applicable to common shares                       (4,665)       (6,463)

     The following sets forth  selected  balance sheet data of the Company as of
the following periods (in thousands):



                                        November 30,   August 31,   November 30,
                                           1997          1998            1998
                                        ------------   ----------   -----------
Balance sheet summary- 
Current assets                          $ 96,978       $ 174,502     $   126,161
Current liabilities                       62,592         116,136          63,216
Working capital                           34,386          58,366          62,945
Property, plant and equipment, net        65,111          66,840          68,028
Total assets                             172,878         251,791         204,465
Outstanding borrowings                    48,109          48,333          57,343
Stockholders' equity                      68,985          80,651          74,538


Three months ended  November 30, 1998,  compared to three months ended  November
30, 1997:

Net sales and  licensing  fees  increased  approximately  $1.9  million  to $7.2
million  from $5.3  million.  The  increase in net sales and  licensing  fees is
primarily the result of increased  sales by the Company's joint venture in China
and increased sales in Australia.

Operating  expenses  increased  from $9.2 million in the first fiscal quarter of
1998 to $11.8 million in fiscal 1999. This expected  increase is attributable to
additional research and product  development,  selling and promotional costs and
the costs incurred for the planned merger with Monsanto.

Interest expense  increased to $0.53 million from $0.34 million primarily due to
higher  outstanding  borrowings,  the effects of which were partially  offset by
lower interest rates.

<PAGE>

LIQUIDITY AND CAPITAL RESOURCES

The seasonal nature of the Company's  business  significantly  impacts cash flow
and working capital requirements.  The Company maintains credit facilities, uses
early  payments  by  customers  and uses cash from  operations  to fund  working
capital needs. For more than 17 years D&PL has borrowed on a short-term basis to
meet seasonal working capital needs.

D&PL  purchases  seed from  contract  growers  in its first  and  second  fiscal
quarters.  Seed conditioning,  treating and packaging commence late in the first
fiscal  quarter  and  continue  through  the  third  fiscal  quarter.   Seasonal
borrowings  normally  commence in the first fiscal quarter and peak in the third
fiscal quarter. Loan repayments normally begin in the middle of the third fiscal
quarter and are typically completed by the first fiscal quarter of the following
year. D&PL also offers distributors, dealers and farmers financial incentives to
make early payments.  To the extent D&PL attracts early payments from customers,
bank borrowings under the credit facility are reduced.

The Company records receivables for licensing fees on Bollgard and Roundup Ready
seed sales as the seed is  shipped,  usually in the  Company's  second and third
quarters.  The Company has contracted the billing and collection  activities for
Bollgard  and Roundup  Ready  licensing  fees to  Monsanto.  In  September,  the
technology fees are due at which time D&PL receives payment from Monsanto.  D&PL
then pays  Monsanto  its royalty for the Bollgard  and Roundup  Ready  licensing
fees.

In April 1998, the Company  entered into a syndicated  credit  facility with its
existing  lender  and  two  other  financial  institutions  which  provides  for
aggregate borrowings of $110 million.  This agreement provides a base commitment
of $55 million and a seasonal commitment of $55 million.  The base commitment is
a long-term loan that may be borrowed upon at any time and is due April 1, 2001.
The seasonal  commitment  is a working  capital loan that may be drawn upon from
September 1 through June 30 of each fiscal year and expires April 1, 2001.  Each
commitment  offers  variable  and fixed  interest  rate options and requires the
Company to pay facility or commitment fees and to comply with certain  financial
covenants.

Capital expenditures for the first fiscal quarter of 1999 were $2.8 million. The
Company  anticipates  that domestic capital  expenditures  will approximate $7.0
million in 1999,  excluding  expected  capital  expenditures  for foreign  joint
ventures which will be funded by cash from operations, borrowings or investments
from joint venture  partners,  as necessary.  Capital  expenditures  in 1999 for
international  ventures  are expected to range from $6.0 million to $8.0 million
depending on the timing and outcome of such projects.

In the  first  quarter  of fiscal  1999,  the Board of  Directors  authorized  a
quarterly   dividend  of  $0.03  per  share,  paid  December  15,  1998  to  the
stockholders  of record on November 30, 1998. It is  anticipated  that quarterly
dividends of $0.03 per share will continue to paid until the planned merger with
Monsanto is  consummated,  although the Board of  Directors  reviews this policy
quarterly.

Cash provided from  operations,  early  payments from  customers and  borrowings
under the loan agreement should be sufficient to meet the Company's 1999 working
capital needs.


<PAGE>

PART II.   OTHER INFORMATION

Item 4.  Submission of Matters to a Vote of Security Holders

A Special Meeting of the stockholders of Delta and Pine Land Company was held on
November 30, 1998, for the following purpose:

     1.   to approve an Agreement and Plan of Merger pursuant to which Delta and
          Pine Land Company will merge with and into Monsanto Company.

The results from the stockholders' meeting are as follows:

Item Number     For               Against             Withheld         Nonvotes
1.           28,447,022           114,235              54,512         9,778,772

Item 6.  Exhibits and Reports on Form 8-K

(a) Exhibits.
     11.01    Computation of Earnings Per Share
 
     27.01    Financial Data Schedule

(b) Reports on Form 8-K.

     No reports on Form 8-K were filed  during the quarter  ended  November  30,
1998.

<PAGE>

                                   SIGNATURES


     Pursuant to the  requirements  of the  Securities and Exchange Act of 1934,
the  registrant  has duly  caused  this report to be signed on its behalf by the
undersigned thereunto duly authorized.


                                            DELTA AND PINE LAND COMPANY


Date:     January 14, 1999                 /s/ Roger D. Malkin
                                           -------------------
                                            Roger D. Malkin, Chairman and
                                            Chief Executive Officer


Date:     January 14, 1999                 /s/ W. Thomas Jagodinski
                                           ------------------------
                                            W. Thomas Jagodinski,
                                          Vice President - Finance and Treasurer

<PAGE>

                                  EXHIBIT 11.01

                        COMPUTATION OF EARNINGS PER SHARE
                      (IN THOUSANDS, EXCEPT PER SHARE DATA)

                           FOR THE THREE MONTHS ENDED

                                                      
                                               November 30,         November 30,
                                                   1997                 1998


BASIC EARNINGS PER SHARE:

WEIGHTED AVERAGE NUMBER OF SHARES OF
   COMMON STOCK OUTSTANDING
   DURING THE PERIOD                               37,721               38,380
                                                  ========             ========
NET LOSS APPLICABLE TO COMMON SHARES             $ (4,665)            $ (6,463)
                                                  ========             ========
   BASIC EARNINGS PER SHARE                      $  (0.12)            $  (0.17)
                                                  ========             ========
DILUTED EARNINGS PER SHARE:

WEIGHTED AVERAGE NUMBER OF SHARES                  37,721               38,380
   OF COMMON STOCK OUTSTANDING
   DURING THE PERIOD

WEIGHTED AVERAGE NUMBER OF SHARES
   OF COMMON STOCK OUTSTANDING
   DURING THE PERIOD FOR COMPUTATION
   OF DILUTED EARNINGS PER SHARE                   37,721               38,380
                                                  =======              ========
   NET LOSS APPLICABLE TO COMMON SHARES          $ (4,641)            $ (6,439)
                                                 =========             ========
   DILUTED EARNINGS PER SHARE                    $  (0.12)           $   (0.17)
                                                 =========             ========




<PAGE> 

<TABLE> <S> <C>

<ARTICLE> 5
<LEGEND>
This schedule contains summary financial information extracted from SEC
form 10-Q and qualified in its entirety by reference to such financial
statements.
</LEGEND>
<MULTIPLIER> 1,000
       
<S>                             <C>
<PERIOD-TYPE>                   3-MOS
<FISCAL-YEAR-END>                          AUG-31-1999
<PERIOD-END>                               NOV-30-1998
<CASH>                                           5,625
<SECURITIES>                                         0
<RECEIVABLES>                                   13,246
<ALLOWANCES>                                         0
<INVENTORY>                                     92,511
<CURRENT-ASSETS>                               126,167
<PP&E>                                          96,936
<DEPRECIATION>                                  28,908
<TOTAL-ASSETS>                                 204,465
<CURRENT-LIABILITIES>                           63,216
<BONDS>                                         57,343
                                0
                                         80
<COMMON>                                         3,852
<OTHER-SE>                                      70,606
<TOTAL-LIABILITY-AND-EQUITY>                   204,465
<SALES>                                          7,195
<TOTAL-REVENUES>                                 7,195
<CGS>                                            4,947
<TOTAL-COSTS>                                   11,842
<OTHER-EXPENSES>                                   237
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                                 531
<INCOME-PRETAX>                               (10,362)
<INCOME-TAX>                                     3,923
<INCOME-CONTINUING>                            (6,439)
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                   (6,439)
<EPS-PRIMARY>                                   (0.17)
<EPS-DILUTED>                                   (0.17)
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission